News
By group, procedural success and freedom from LVOT obstruction (LVOT mean gradient > 50 mm Hg), the primary efficacy endpoint ...
The U.S. Food and Drug Administration has approved Edwards Lifesciences' SAPIEN 3 platform, a transcatheter aortic valve ...
Many multi-column gas chromatography systems use two-position multi-port switching valves, which can suffer from delays in ...
but that’s not how the new Edwards Lifesciences Sapien M3 transcatheter mitral valve replacement (TMVR) system uses nitinol’s shape memory properties. Like the Sapien 3 heart valve it’s based on, the ...
Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of ...
The Swiss flow solutions provider expands its center of excellence for valve actuation in Italy. Together with the previously opened sites in the United States and Switzerland, GF Piping Systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results